MedTrace Logo

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

NCT06155513 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2026-04-22

No results posted yet for this study

Summary

This exploratory study aims to verify the impact on the severity of eczema as well as the prebiotic potential of a daily application of Omega-3 serum and cream on a skin with eczema. This study will also collect data on possible adverse effects of the products. Sixteen participants will be enrolled in this study and will be divided in two groups of 8 subjects that will receive two different treatments for forty-two days. The baseline condition will serve as a control for the effects observed after treatment on the targeted eczema area.

Conditions

Interventions

COMBINATION_PRODUCT

Omega-3 monoglyceride based topical Serum and cream of formulation A (light)

Omega-3 monoglyceride based serum and cream of lighter formulation

COMBINATION_PRODUCT

Omega-3 monoglyceride based topical Serum and cream of formulation B (rich)

Omega-3 monoglyceride based serum and cream with a richer formulation

Sponsors & Collaborators

  • SCF Pharma

    lead INDUSTRY

Principal Investigators

  • Samuel P Fortin, Ph.D · SCF Pharma

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-20
Primary Completion
2025-11-05
Completion
2025-11-05

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06155513 on ClinicalTrials.gov